申请人:Harbeson Scott L.
公开号:US20110313004A1
公开(公告)日:2011-12-22
This invention relates to novel substituted pyridinones, their deuterium-modified derivatives and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a TNF (tumor necrosis factor) alpha production inhibitor/TGF (transforming growth factor) beta inhibitor.
本发明涉及新型取代吡啶酮、其氘代衍生物及其药学上可接受的盐。该发明还提供了包含本发明化合物的组合物,以及使用这些组合物治疗通过给予TNF(肿瘤坏死因子)α生产抑制剂/TGF(转化生长因子)β抑制剂治疗有益的疾病和病况的方法。